MannKind (NASDAQ:MNKD) shares are trading higher in pre-market trading after the company announced a worldwide licensing and collaboration agreement with Rose Pharma to develop ROSE-010 Technosphere, an inhaled, rapid-acting glucagon-like peptide-1 receptor agonist for weight management. MannKind is a biopharmaceutical company focused on developing …
The US sector performance data for 8 September 2026 showed a clear divergence between Energy and defensive Utilities on one side and most other sectors on the other. Energy gained 1.11%, Utilities advanced 0.86% and Technology rose 0.32%, while eight sectors finished lower. The …
Immuron Limited (NASDAQ: IMRN) shares closed up 62% at $1.80 after the company entered an exclusive distribution agreement within the United States with Calmino Group AB for PROIBS.
NeuroSense Therapeutics Ltd. (NASDAQ: NRSN) shares closed up 27% at $0.51 after the company unveiled a refined PrimeC development plan for ALS, leveraging AI-driven formulation insights and a streamlined Phase 3 PARAGON trial design.
Clearmind Medicine Inc. (NASDAQ: CMND) shares closed down 32% at $1.16 after the company entered a definitive agreement to acquire a 51% stake in EV wireless charging company Charging Robotics for $2.5 million plus a $1.5 million 4% loan.
Nano-X Imaging Ltd. (NASDAQ: NNOX) shares closed up 16% at $0.83 afterSubsidiaryNanox Impact entered a regional distribution partnership with Associated X-Ray Imaging to commercialize and maintain the Nanox.ARC 3D digital tomosynthesis system across New England.
Aethlon Medical, Inc. (NASDAQ: AEMD) shares closed down 6% at $1.82 despite the company securing a notice of allowance from the USPTO for a patent regarding technology for managing viral infections and their symptoms.
Modular Medical, Inc. (NASDAQ: MODD) shares closed up 8% at $3.68 after the company secured a contract with a national U.S. pharmacy benefit manager for its Pivot tubeless insulin patch pump.
Jaguar Health, Inc. (NASDAQ: JAGX) shares closed down 14% at $0.60 after the company broadened compassionate-use availability for oral crofelemer to treat an infant with congenital sodium diarrhea-linked intestinal failure.
That pivot has been advanced through MARA's Exaion acquisition and its Starwood data center partnership, both of which are positioned as steps toward diversifying the company'sRevenuebase beyond bitcoin mining alone.